Table 2.
COVID-19 | Baseline (2016–2018) | |||||||
---|---|---|---|---|---|---|---|---|
Time periods (min) | Mean | STD | Mean | STD | z | p | Baseline upper limit | N (%) of patients exceeding upper reference limit |
Onset–to-door | 84.1 | 21.4 | 86.2 | 46.44 | 0.18 | 0.850 | 178 | 0 (0%) |
Door-to-first CT/MRI | 54.9 | 18.5 | 30.62 | 31.62 | 3.07 | 0.002 | 108 | 0 (0%) |
Door-to-needle | 100.7 | 40.4 | 77.39 | 36.12 | 1.81 | 0.070 | 167.7 | 0(0%) |
Door-to-groin puncture | 189.1 | 49.2 | 137.12 | 75.13 | 2.49 | 0.010 | 308.8 | 1 (6.2%) |
The z and p-values refer to the comparisons of the means.